Ohio cancer center gets $20M to study tobacco for FDA

Columbus-based Ohio State University Comprehensive Cancer Center was awarded $20 million by the Tobacco Center of Regulatory Science to gather evidence needed to inform the FDA’s regulation of tobacco products.

Advertisement

OSU was one of seven centers to receive a grant for the research. The centers will conduct research in epidemiology, economics, toxicology and marketing. The university plans to use “the tobacco industry’s nicotine playbook” to improve public health through four research projects, according to an Oct. 4 hospital news release.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Public Health

Advertisement

Comments are closed.